Table I.
PD-L1 | |||
---|---|---|---|
Variable | + | − | P-value |
Age, years | 0.312 | ||
<65 | 48 | 159 | |
≥65 | 12 | 27 | |
Sex, n | 0.942 | ||
Female | 6 | 18 | |
Male | 54 | 168 | |
CCI | 0.600 | ||
Low | 8 | 19 | |
Moderate | 51 | 160 | |
High | 1 | 7 | |
Vessel invasion | 0.137 | ||
Yes | 13 | 59 | |
No | 47 | 127 | |
Differentiation | 0.542 | ||
Well | 17 | 67 | |
Moderate | 36 | 101 | |
Poor | 7 | 18 | |
Tumor location | 0.209 | ||
Upper | 21 | 77 | |
Middle | 39 | 103 | |
Lower | 0 | 6 | |
T stage | 0.109 | ||
1–2 | 10 | 136 | |
3–4 | 50 | 50 | |
N stage | 0.213 | ||
0–1 | 33 | 119 | |
2–3 | 27 | 67 | |
TMN stagea | 0.022 | ||
II | 27 | 132 | |
III | 33 | 54 | |
Smoking history | 0.837 | ||
Yes | 47 | 148 | |
No | 13 | 38 | |
Alcohol consumption | 0.892 | ||
Yes | 46 | 141 | |
No | 14 | 45 |
According to the 7th American Joint Committee on Cancer guidelines. CCI, Charlson comorbidity index; TNM, tumor-node metastasis; T stage, tumor stage; N stage, node stage; PD-L1, programmed death-ligand 1.